Medicare Enrolled

Dr. Jose Birriel, MD

Pulmonary Disease · Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
351 NW 42ND AVE STE 406, Miami, FL 33126
3056422600
In practice since 2006 (19 years)
NPI: 1104835099 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Birriel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Birriel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Birriel

Dr. Jose Birriel is a pulmonary disease in Miami, FL, with 19 years in practice. Based on federal Medicare data, Dr. Birriel performed 86 Medicare services across 51 unique beneficiaries.

Between the years covered by Open Payments, Dr. Birriel received a total of $3,030 from 17 pharmaceutical and/or device companies across 155 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Birriel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 86 Medicare services$ $3,030 industry payments

Medicare Practice Summary

Medicare Utilization ↗
86
Medicare services
Bottom 6% in FL for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
51
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Inhalation treatment for airway obstruction or sputum production24$8$50
Office visit, established patient (30-39 min)22$108$195
Follow-up therapy service to facilitate lung function20$30$80
Steroid injection (triamcinolone)20$1$25
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,030
Total received (2018-2024)
Avg $433/year across 7 years
Top 48% in FL for pulmonary disease
17
Companies
155
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,898 (95.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$132 (4.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$115
2023
$116
2022
$345
2021
$299
2020
$278
2019
$687
2018
$1,189

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Actelion Pharmaceuticals US, Inc.
$593
GlaxoSmithKline, LLC.
$590
AstraZeneca Pharmaceuticals LP
$572
Boehringer Ingelheim Pharmaceuticals, Inc.
$292
Philips Electronics North America Corporation
$292
Insmed, Inc.
$189
Mylan Specialty L.P.
$143
Allergan Inc.
$125
Novartis Pharmaceuticals Corporation
$64
kaleo, Inc.
$28
Regeneron Healthcare Solutions, Inc.
$25
Covis Pharma B.V.
$24
GENZYME CORPORATION
$22
Ambu Inc.
$20
Biogen, Inc.
$18
Nabriva Therapeutics, plc
$18
Kaleo, Inc.
$15
Top 3 companies account for 57.9% of total payments
Associated products mentioned in payments ›
(8874) inCourage · ALVESCO · ANORO · AUVI-Q · AVYCAZ · Arikayce · BREO · BREZTRI · DUPIXENT · FASENRA · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · SPINRAZA · STIOLTO RESPIMAT · SYMBICORT · SYNAGIS · TEZSPIRE · TRELEGY ELLIPTA · Trilogy 100 · UPTRAVI · Wellcentive Undiv · XOLAIR · Xenleta · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $3,524 per 100 Medicare services performed
Looking for a pulmonary disease in Miami?
Compare pulmonary diseases in the Miami area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
128
Per 100K population
4.8
County median income
$68,694
Nearest hospital
CORAL GABLES HOSPITAL
2.6 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Birriel is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Birriel experienced with inhalation treatment for airway obstruction or sputum production?
Based on Medicare claims data, Dr. Birriel performed 24 inhalation treatment for airway obstruction or sputum production services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Birriel receive payments from pharmaceutical companies?
Yes. Dr. Birriel received a total of $3,030 from 17 companies across 155 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Birriel's costs compare to other pulmonary diseases in Miami?
Dr. Birriel's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Birriel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →